drugset / Trial / NCT02967614

KJ-TFC-004 Drug-drug Interaction Study

NCT02967614

Phase 1 Completed 32 enrolled Kukje Pharma
RandomizedParallel-groupOpen-labelTreatment

Summary

To assess the pharmacokinetic Interaction between Dorzolamide and Brimonidine in healthy male subjects.

Timeline

Start
2016-12
Primary completion
2017-12
Completion
2018-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Brimonidine Small molecule Other
Subject Dorzolamide Small molecule Other
Subject Timolol Other / unclassified Other